MOTS-C (MS40) is a short peptide research product derived from mitochondria, used to explore mechanisms related to mitochondrial function, cellular metabolic regulation, and energy homeostasis.
MOTS-C (MS40) is a small bioactive peptide derived from the open reading frame of mitochondrial 12S rRNA, belonging to the mitochondrial-derived peptide (MDP) family. This 16-amino acid peptide is valuable for research related to mitochondrial signaling regulation. MOTS-C is typically supplied as a white to off-white lyophilized powder, and its quality is assessed by HPLC purity detection and LC-MS identification. As a research tool, MOTS-C is primarily used to study mitochondrial communication mechanisms, cellular energy metabolism regulation, and metabolic homeostasis-related biological processes.
MOTS-C is primarily used in mitochondrial biology, cell metabolism, and molecular signaling research. Researchers utilize MOTS-C to study mitochondrial function regulation, AMPK-related signaling pathways, changes in energy metabolism, oxidative stress responses, and cellular metabolic adaptation mechanisms. Simultaneously, this research peptide can be used to explore the effects of mitochondrial-derived signaling molecules on cellular function, metabolic networks, and cellular homeostasis regulation.
Freeze-dried powder state:
Recommended:
Long-term storage:
-20℃
Requirements:
✅ Protect from light
✅ Dry
✅ Store in an airtight container
Avoid:
High temperatures
Repeated freeze-thaw cycles
Prolonged exposure to air
Acetate BPC-157 (BC10) is a synthetic polypeptide research compound composed of ...
BPC-157 5mg + TB-500 5mg (BB10) is a compound lyophilized product composed of tw...
BPC-157 10mg + TB-500 10mg (BB20) is a compound research peptide product compose...
Contact our team for volume discounts and custom peptide services
Weitai Bio is a national high-tech enterprise specializing in the research, development, production, and sales of peptide drugs. It is also a leading global supplier of high-quality peptides, consistently focusing on peptide drugs and small nucleic acid fields.